43/120
1.8 / 5 stars
All 120 Win/Lose results shown below
INSM Roast Me summary
INSMED Inc (INSM). Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
- 2026-Q2: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Win; Revenue growth Win; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Win; EPS growth Lose.
Trailing 1 year (4 quarters): 6 wins, 6 lossesLast fetched: 24 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q21/3 |
LoseINSM / S&P -34.80% / 15.20% |
WinINSM / S&P 185.76% / 15.00% |
LoseINSM / S&P INSM unavailable / 50.40% |
| 2026-Q11/3 |
LoseINSM / S&P -6.04% / -4.33% |
WinINSM / S&P 115.09% / 11.30% |
LoseINSM / S&P INSM unavailable / 27.70% |
| 2025-Q42/3 |
WinINSM / S&P 20.85% / 2.65% |
WinINSM / S&P 66.73% / 9.00% |
LoseINSM / S&P INSM unavailable / 13.40% |
| 2025-Q32/3 |
WinINSM / S&P 43.09% / 8.12% |
WinINSM / S&P 30.34% / 4.61% |
LoseINSM / S&P INSM unavailable / 13.45% |
| 2025-Q22/3 |
WinINSM / S&P 31.92% / 10.94% |
WinINSM / S&P 21.15% / 4.83% |
LoseINSM / S&P INSM unavailable / 10.63% |
| 2025-Q12/3 |
WinINSM / S&P 10.50% / -4.27% |
WinINSM / S&P 20.77% / 4.98% |
LoseINSM / S&P INSM unavailable / 10.57% |
| 2024-Q41/3 |
LoseINSM / S&P -5.42% / 2.41% |
WinINSM / S&P 19.17% / 5.25% |
LoseINSM / S&P INSM unavailable / 6.15% |
| 2024-Q32/3 |
WinINSM / S&P 8.96% / 5.89% |
WinINSM / S&P 22.13% / 5.89% |
LoseINSM / S&P INSM unavailable / 6.11% |
| 2024-Q22/3 |
WinINSM / S&P 146.96% / 4.28% |
WinINSM / S&P 21.94% / 5.38% |
LoseINSM / S&P INSM unavailable / 5.12% |
| 2024-Q11/3 |
LoseINSM / S&P -12.46% / 10.56% |
WinINSM / S&P 22.54% / 5.71% |
LoseINSM / S&P INSM unavailable / 5.59% |
| 2023-Q42/3 |
WinINSM / S&P 22.73% / 11.69% |
WinINSM / S&P 24.39% / 6.81% |
LoseINSM / S&P INSM unavailable / 7.78% |
| 2023-Q32/3 |
WinINSM / S&P 19.67% / -3.27% |
WinINSM / S&P 15.95% / 7.52% |
LoseINSM / S&P INSM unavailable / -5.03% |
| 2023-Q22/3 |
WinINSM / S&P 23.75% / 8.74% |
WinINSM / S&P 21.82% / 9.50% |
LoseINSM / S&P INSM unavailable / -8.57% |
| 2023-Q11/3 |
LoseINSM / S&P -14.66% / 7.50% |
WinINSM / S&P 27.87% / 10.77% |
LoseINSM / S&P INSM unavailable / -15.69% |
| 2022-Q41/3 |
LoseINSM / S&P -7.24% / 7.56% |
WinINSM / S&P 30.19% / 11.88% |
LoseINSM / S&P INSM unavailable / -17.99% |
| 2022-Q32/3 |
WinINSM / S&P 9.23% / -4.88% |
WinINSM / S&P 39.38% / 13.47% |
LoseINSM / S&P INSM unavailable / -1.41% |
| 2022-Q22/3 |
WinINSM / S&P -16.09% / -16.10% |
WinINSM / S&P 29.64% / 13.71% |
LoseINSM / S&P INSM unavailable / 11.04% |
| 2022-Q11/3 |
LoseINSM / S&P -13.73% / -4.60% |
WinINSM / S&P 20.02% / 15.97% |
LoseINSM / S&P INSM unavailable / 42.23% |
| 2021-Q40/3 |
LoseINSM / S&P -1.09% / 11.03% |
LoseINSM / S&P 14.63% / 15.00% |
LoseINSM / S&P INSM unavailable / 96.40% |
| 2021-Q30/3 |
LoseINSM / S&P -3.23% / 0.58% |
LoseINSM / S&P 2.99% / 10.77% |
LoseINSM / S&P INSM unavailable / 69.42% |
| 2021-Q20/3 |
LoseINSM / S&P -16.44% / 8.55% |
LoseINSM / S&P 4.08% / 6.58% |
LoseINSM / S&P INSM unavailable / 51.81% |
| 2021-Q11/3 |
LoseINSM / S&P 2.31% / 6.17% |
WinINSM / S&P 10.79% / -1.06% |
LoseINSM / S&P INSM unavailable / 7.39% |
| 2020-Q41/3 |
LoseINSM / S&P 3.58% / 12.15% |
WinINSM / S&P 20.48% / -3.72% |
LoseINSM / S&P INSM unavailable / -33.42% |
| 2020-Q32/3 |
WinINSM / S&P 16.70% / 8.93% |
WinINSM / S&P 67.71% / -2.04% |
LoseINSM / S&P INSM unavailable / -27.10% |
| 2020-Q22/3 |
WinINSM / S&P 71.80% / 20.54% |
WinINSM / S&P 165.68% / -0.46% |
LoseINSM / S&P INSM unavailable / -27.11% |
| 2020-Q11/3 |
LoseINSM / S&P -32.87% / -19.60% |
WinINSM / S&P 377.12% / 3.47% |
LoseINSM / S&P INSM unavailable / -14.75% |
| 2019-Q42/3 |
WinINSM / S&P 35.37% / 9.07% |
WinINSM / S&P 1287.56% / 5.36% |
LoseINSM / S&P INSM unavailable / 2.99% |
| 2019-Q30/3 |
LoseINSM / S&P -31.09% / 1.70% |
LoseINSM / S&P INSM unavailable / 5.02% |
LoseINSM / S&P INSM unavailable / 0.21% |
| 2019-Q20/3 |
LoseINSM / S&P -11.94% / 4.30% |
LoseINSM / S&P INSM unavailable / 6.64% |
LoseINSM / S&P INSM unavailable / 8.65% |
| 2019-Q11/3 |
WinINSM / S&P 121.57% / 13.65% |
LoseINSM / S&P INSM unavailable / 8.12% |
LoseINSM / S&P INSM unavailable / 14.29% |
| 2018-Q40/3 |
LoseINSM / S&P -35.11% / -13.52% |
LoseINSM / S&P INSM unavailable / 9.05% |
LoseINSM / S&P INSM unavailable / 18.23% |
| 2018-Q30/3 |
LoseINSM / S&P -14.50% / 7.71% |
LoseINSM / S&P INSM unavailable / 10.21% |
LoseINSM / S&P INSM unavailable / 19.06% |
| 2018-Q21/3 |
WinINSM / S&P 5.02% / 3.43% |
LoseINSM / S&P INSM unavailable / 9.03% |
LoseINSM / S&P INSM unavailable / 14.46% |
| 2018-Q10/3 |
LoseINSM / S&P -27.77% / -0.76% |
LoseINSM / S&P INSM unavailable / 7.68% |
LoseINSM / S&P INSM unavailable / 12.46% |
| 2017-Q40/3 |
LoseINSM / S&P -0.10% / 6.64% |
LoseINSM / S&P INSM unavailable / 7.03% |
LoseINSM / S&P INSM unavailable / 13.82% |
| 2017-Q31/3 |
WinINSM / S&P 81.88% / 4.48% |
LoseINSM / S&P INSM unavailable / 5.68% |
LoseINSM / S&P INSM unavailable / 17.57% |
| 2017-Q20/3 |
LoseINSM / S&P -2.00% / 3.09% |
LoseINSM / S&P INSM unavailable / 4.83% |
LoseINSM / S&P INSM unavailable / 17.74% |
| 2017-Q11/3 |
WinINSM / S&P 32.35% / 6.07% |
LoseINSM / S&P INSM unavailable / 3.67% |
LoseINSM / S&P INSM unavailable / 13.32% |
| 2016-Q40/3 |
LoseINSM / S&P -8.88% / 3.82% |
LoseINSM / S&P INSM unavailable / 2.09% |
LoseINSM / S&P INSM unavailable / 7.05% |
| 2016-Q31/3 |
WinINSM / S&P 47.26% / 3.85% |
LoseINSM / S&P INSM unavailable / 0.20% |
LoseINSM / S&P INSM unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-28
| Metric | INSM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -12.91% | 20.78% |
| Annualized return | -12.91% | 20.78% |
5Y · 2021-09-01 to 2026-08-28
| Metric | INSM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 306.88% | 83.14% |
| Annualized return | 32.40% | 12.86% |
10Y · 2016-09-01 to 2026-08-28
| Metric | INSM total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 785.17% | 319.30% |
| Annualized return | 24.37% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-24.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Viatris Inc (VTRS) | United States | $20.008B | -0.00 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |